<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="pathogens-09-00137-t001" orientation="portrait" position="float">
 <object-id pub-id-type="pii">pathogens-09-00137-t001_Table 1</object-id>
 <label>Table 1</label>
 <caption>
  <p>Clinical, laboratory and virological characteristics of immunocompetent and immunosuppressed HEV RNA positive patients.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"> </th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Immunocompetent Patients 
     <break/>
     <italic>n</italic> = 13
    </th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Immunosuppressed Patients
     <break/>
     <italic>n</italic> = 48
    </th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
     <italic>p</italic>
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Age in years</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.5 (46–61.5)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">51 (26–58)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <bold>0.044</bold>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sex (m/f)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12/1</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35/13</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.264</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HEV RNA at diagnosis, IU/mL</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.06 × 10
     <sup>6</sup> (0.41 × 10
     <sup>6</sup>–5 × 10
     <sup>6</sup>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.27 × 10
     <sup>6</sup> (0.1 × 10
     <sup>6</sup>–5 × 10
     <sup>6</sup>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.899</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ALT, IU/mL
     <break/>
     <italic>n</italic> = 58
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2351 (1546–3443)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">138 (38–413)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <bold>&lt;0.001</bold>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ALT &gt; ULN, n,%
     <break/>
     <italic>n</italic> = 59
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13 (100%)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38 (82.6%)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.180</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IgG, g/L
     <break/>
     <italic>n</italic> = 29
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.1 (9.9–14.6)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.9 (6.95–12.2)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <bold>0.011</bold>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ANA positivity, n, %
     <break/>
     <italic>n</italic> = 24
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7 (63.6%)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 (23%)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.095</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Death/Survival</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4/9</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2/46</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <bold>0.016</bold>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Liver failure (yes/no)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6/7</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1/47</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <bold>&lt;0.001</bold>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chronification (yes/no)
     <break/>
     <italic>n</italic> = 45
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0/5</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13/27</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.301</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HEV IgM (S/CO)
     <break/>
     <italic>n</italic> = 60
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.35 (3.12–7.62)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.72 (0.84–6.68)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.056</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HEV IgG (S/CO)
     <break/>
     <italic>n</italic> = 60
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.49 (0.88–6.32)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.19 (0.51–5.59)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.355</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HEV IgA (S/CO)
     <break/>
     <italic>n</italic> = 34
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.63 (3.39–4.65)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.33 (0.32–3.59)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <bold>0.012</bold>
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>Data are presented as median (IQR) for continuous variables and n, percentage for categorical variables. For comparisons between groups, we used Chi Square, Fisher’s exact test, unpaired t-test or Mann–Whitney U. ALT: alanine aminotransferase, ULN: under the normal limit, ANA: antinuclear antibodies.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
